United Therapeutics
UTHR
UTHR
373 hedge funds and large institutions have $6.01B invested in United Therapeutics in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 155 increasing their positions, 130 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
373
Holders Change
-37
Holders Change %
-9.02%
% of All Funds
9.31%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.12%
New
31
Increased
155
Reduced
130
Closed
62
Calls
$29.9M
Puts
$114M
Net Calls
-$84.1M
Net Calls Change
-$80.9M
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$58.7M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$55.9M |
| 3 |
Goldman Sachs
New York
|
+$54.6M |
| 4 |
JPMorgan Chase & Co
New York
|
+$49M |
| 5 |
Renaissance Technologies
New York
|
+$43M |
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$216M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$112M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$103M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$86.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$43.2M |
